Thomas K. Equels, CEO & President

HEB 811,707 shares

The estimated Net Worth of Thomas K. Equels is at least $142,454.58. Thomas K. Equels owns over 811,707 units of Hemispherx Biopharma, Inc. stock worth over $142,454.58.

Transaction DateCompanySharesTypeOwnedPriceValuePost Value
27th February 2019HEB - Hemispherx Biopharma, Inc.325,000Exercise of in-the-money or at-the-money derivatives securities (usually options)325,000$0.00
27th February 2019HEB - Hemispherx Biopharma, Inc.65Exercise of in-the-money or at-the-money derivatives securities (usually options)65$0.00
19th March 2019HEB - Hemispherx Biopharma, Inc.13,400Open or private purchase811,707$0.18$2,351.70$142,454.58
8th May 2019HEB - Hemispherx Biopharma, Inc.227,500Conversion of derivative1,364,207$0.00
18th March 2019HEB - Hemispherx Biopharma, Inc.325,000Conversion of derivative1,136,707$0.00
21st June 2019HEB - Hemispherx Biopharma, Inc.29,404Open or private purchase1,393,611$4.03$118,498.12$5,616,252.33
27th June 2019HEB - Hemispherx Biopharma, Inc.2,632Open or private purchase63,041$4.37$11,501.84$275,489.17
15th October 2019HEB - Hemispherx Biopharma, Inc.13,470Grant/award etc.76,511$0.58$7,812.60$44,376.38
31st October 2019HEB - Hemispherx Biopharma, Inc.15,625Grant/award etc.92,136$0.50$7,812.50$46,068.00
15th November 2019HEB - Hemispherx Biopharma, Inc.16,622Grant/award etc.108,758$0.47$7,812.34$51,116.26
29th November 2019HEB - Hemispherx Biopharma, Inc.19,531Grant/award etc.128,289$0.40$7,812.40$51,315.60
13th December 2019HEB - Hemispherx Biopharma, Inc.17,960Grant/award etc.146,249$0.44$7,812.60$63,618.32
31st December 2019HEB - Hemispherx Biopharma, Inc.14,741Grant/award etc.160,990$0.53$7,812.73$85,324.70
21st August 2020HEB - Hemispherx Biopharma, Inc.10,730Open or private purchase171,717$2.33$25,000.90$400,100.61
3rd September 2020HEB - Hemispherx Biopharma, Inc.12,316Open or private purchase184,033$2.03$25,001.48$373,586.99